We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Iris AI Stock

Invest in or calculate the value of your shares in Iris AI or other pre-IPO companies through EquityZen's platform.

Get Started

Iris AI Stock (IRAI)

Iris is an AI Science Assistant, helping R&D double productivity when seeking out new opportunities in published research.

About Iris AI Stock

Founded

2015

Total Funding

380K

Industries

Software, Data and Analytics, Science and Engineering

Iris AI is your Science assistant, helping you map out relevant research for your thesis work or R&D project. She will double your productivity over existing tools such as Google Scholar. The flow is simple. Give Iris the URL to a research paper. She reads the abstract, maps out the key concepts and presents you with the most relevant articles from more than 30M Open Access papers. With a nicely visualized overview you can navigate around until you find what you need, and directly download the paper. Spend your time reviewing relevant articles rather than trying to formulate key words in a field you don't know yet. Scithons show that research teams using Iris more than double their productivity - their identification of key papers and their understanding of the problem space - compared to existing tools. (http://iris.ai/journey/great-results-first-scithon/) Iris AI services a volume market consisting of Master Thesis and PhD students, and targets R&D departments and Research Institutes with their paid solutions.

Iris AI Management

Leadership team at Iris AI

Senior Research Engineer

Kaloyan Marinov

CTO & Co-Founder

Victor Botev

Locked Features

Join now and verify your accreditation status to gain access to:

  • Iris AI current valuation
  • Iris AI stock price
  • Available deals in Iris AI and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading Iris AI Stock

How to invest in Iris AI stock?

Accredited investors can buy pre-IPO stock in companies like Iris AI through EquityZen funds. These investments are made available by existing Iris AI shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Iris AI stock?

Shareholders can sell their Iris AI stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."